JP2020510044A5 - - Google Patents

Download PDF

Info

Publication number
JP2020510044A5
JP2020510044A5 JP2019549454A JP2019549454A JP2020510044A5 JP 2020510044 A5 JP2020510044 A5 JP 2020510044A5 JP 2019549454 A JP2019549454 A JP 2019549454A JP 2019549454 A JP2019549454 A JP 2019549454A JP 2020510044 A5 JP2020510044 A5 JP 2020510044A5
Authority
JP
Japan
Prior art keywords
alkyl
carbocyclyl
compound
alkoxy
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019549454A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020510044A (ja
JP7323179B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/021848 external-priority patent/WO2018165611A1/en
Publication of JP2020510044A publication Critical patent/JP2020510044A/ja
Publication of JP2020510044A5 publication Critical patent/JP2020510044A5/ja
Application granted granted Critical
Publication of JP7323179B2 publication Critical patent/JP7323179B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019549454A 2017-03-10 2018-03-09 排出ポンプ阻害剤としてのインドール誘導体 Active JP7323179B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762469987P 2017-03-10 2017-03-10
US62/469,987 2017-03-10
US201762523154P 2017-06-21 2017-06-21
US62/523,154 2017-06-21
PCT/US2018/021848 WO2018165611A1 (en) 2017-03-10 2018-03-09 Indole derivatives as efflux pump inhibitors

Publications (3)

Publication Number Publication Date
JP2020510044A JP2020510044A (ja) 2020-04-02
JP2020510044A5 true JP2020510044A5 (enExample) 2021-04-15
JP7323179B2 JP7323179B2 (ja) 2023-08-08

Family

ID=62044950

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019549454A Active JP7323179B2 (ja) 2017-03-10 2018-03-09 排出ポンプ阻害剤としてのインドール誘導体

Country Status (12)

Country Link
US (1) US11993571B2 (enExample)
EP (1) EP3592736A1 (enExample)
JP (1) JP7323179B2 (enExample)
KR (1) KR102697360B1 (enExample)
CN (1) CN110770224B (enExample)
AU (1) AU2018231120B2 (enExample)
BR (1) BR112019018691A2 (enExample)
CA (1) CA3061238A1 (enExample)
IL (1) IL269210B2 (enExample)
MX (1) MX2019010717A (enExample)
SG (1) SG11201908351TA (enExample)
WO (1) WO2018165611A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10556854B2 (en) 2016-02-24 2020-02-11 Rutgers, The State University Of New Jersey Bacterial efflux pump inhibitors
US10836706B2 (en) 2016-02-24 2020-11-17 Rutgers, The State University Of New Jersey Bacterial efflux pump inhibitors
WO2018165614A1 (en) 2017-03-10 2018-09-13 Rutgers, The State University Of New Jersey Bacterial efflux pump inhibitors
EP3592736A1 (en) 2017-03-10 2020-01-15 Rutgers, the State University of New Jersey Indole derivatives as efflux pump inhibitors
WO2018165612A1 (en) 2017-03-10 2018-09-13 Rutgers, The State University Of New Jersey Bacterial efflux pump inhibitors
CN111163774A (zh) 2017-05-26 2020-05-15 罗格斯新泽西州立大学 细菌外排泵抑制剂
US11458121B2 (en) 2017-06-26 2022-10-04 Rutgers, The State University Of New Jersey Therapeutic compounds and methods to treat infection
WO2019099402A1 (en) * 2017-11-14 2019-05-23 Rutgers, The State University Of New Jersey Therapeutic compounds and methods to treat infection
KR102704123B1 (ko) 2019-11-01 2024-09-06 에스엘 주식회사 차량용 램프
CN121695288A (zh) 2020-02-19 2026-03-20 Epizyme股份有限公司 Setd2抑制剂和相关方法和用途,包括组合疗法
EP4766445A1 (en) 2023-08-23 2026-07-01 Taxis Pharmaceuticals, Inc. BACTERIAL EFFLUX PUMP INHIBITORS
EP4770630A1 (en) * 2023-08-29 2026-07-08 Maze Therapeutics, Inc. Inhibitors of solute carrier family 6a member 19 (slc6a19) and methods of use thereof

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3238215A (en) * 1963-10-17 1966-03-01 Sterling Drug Inc 1-[(3-, 2-, and 1-indolyl)-lower-alkyl-, lower-alkenyl-, and lower-alkynyl]piperidines
US3465080A (en) * 1968-10-07 1969-09-02 American Cyanamid Co Therapeutic compositions containing morpholinoalkylene - indoles and methods of administering such in the treatment of depression
US3978224A (en) 1975-07-01 1976-08-31 Schering Corporation Antimicrobial halo-substituted-2-cyanoethylaminoalkyl-3-phenyl-indoles
US4910193A (en) * 1985-12-16 1990-03-20 Sandoz Ltd. Treatment of gastrointestinal disorders
US4938949A (en) 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
AU8501291A (en) 1990-09-10 1992-03-30 Upjohn Company, The Cis-n-(2-aminocyclohexyl)benzamide and their enantiomers as anticonvulsants
US5864039A (en) * 1994-03-30 1999-01-26 Yoshitomi Pharmaceutical Industries, Ltd. Benzoic acid compounds and use thereof as medicaments
US5663152A (en) 1995-01-19 1997-09-02 Asahi Kasei Kogyo Kabushiki Kaisha Potentiators for aminoglycosides
US6506339B1 (en) * 1997-02-10 2003-01-14 Biomedical Design, Inc. Method of sterilization
AU2337599A (en) * 1998-01-23 1999-08-09 Microcide Pharmaceuticals, Inc. Efflux pump inhibitors
US6204279B1 (en) 1998-06-03 2001-03-20 Microcide Pharmaceuticals, Inc. Peptidomimetic efflux pump inhibitors
AU757777B2 (en) 1998-12-04 2003-03-06 Influx, Inc. Inhibitors of multidrug transporters
JP4831907B2 (ja) 1999-10-08 2011-12-07 アフィニアム・ファーマシューティカルズ・インコーポレイテッド FabI阻害剤
US6730684B1 (en) 1999-10-08 2004-05-04 Affinium Pharmaceuticals, Inc. Fab I inhibitors
US6555569B2 (en) 2000-03-07 2003-04-29 Pfizer Inc. Use of heteroaryl substituted N-(indole-2-carbonyl-) amides for treatment of infection
WO2003000657A1 (en) 2001-06-20 2003-01-03 Daiichi Pharmaceutical Co., Ltd. Diamine derivatives
HUP0103986A2 (hu) * 2001-09-28 2003-06-28 Richter Gedeon Vegyészeti Gyár Rt. Új karbonsavamid szerkezetet tartalmazó piperidinil vegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
EP1314733A1 (en) * 2001-11-22 2003-05-28 Aventis Pharma Deutschland GmbH Indole-2-carboxamides as factor Xa inhibitors
WO2004062674A2 (en) 2003-01-07 2004-07-29 Paratek Pharmaceuticals, Inc. Substituted polyamines as inhibitors of bacterial efflux pumps
GB0403038D0 (en) * 2004-02-11 2004-03-17 Novartis Ag Organic compounds
US7994225B2 (en) 2004-03-17 2011-08-09 Rempex Pharmaceuticals, Inc. Bacterial efflux pump inhibitors for the treatment of ophthalmic and otic infections
EP1758920A1 (en) 2004-05-21 2007-03-07 Mpex Pharmaceuticals, Inc. Bacterial efflux pump inhibitors and methods of treating bacterial infections
EP1817025A2 (en) 2004-11-23 2007-08-15 PTC Therapeutics, Inc. Tetrahydrocarbazoles as active agents for inhibiting vegf production by translational control
US7855228B2 (en) 2005-02-10 2010-12-21 The Board Of Trustees Of The Leland Stamford Junior University Antibiotics targeting MreB
US7807704B2 (en) 2006-03-30 2010-10-05 Chemocentryx, Inc. Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2
FR2904317A1 (fr) * 2006-07-27 2008-02-01 Inst Nat Sante Rech Med Analogues d'halogenobenzamides marques a titre de radiopharmaceutiques
CA3144493A1 (en) 2006-10-03 2008-04-10 Arbutus Biopharma Corporation Lipid containing formulations
AR070398A1 (es) * 2008-02-22 2010-03-31 Gruenenthal Chemie Derivados sustituidos de indol
WO2009110002A1 (en) 2008-03-05 2009-09-11 Council Of Scientific & Industrial Research Novel efflux pump inhibitors
US20110237578A1 (en) 2008-09-18 2011-09-29 Zhi-Liang Wei Amide compounds, compositions and uses thereof
US8173636B2 (en) 2009-04-03 2012-05-08 Achillion Pharmaceuticals, Inc. Hydroxylthienoquinolones and related compounds as anti-infective agents
EP2536408A1 (en) 2010-02-16 2012-12-26 Wockhardt Research Centre Efflux pump inhibitors
EP2394653A1 (en) * 2010-05-26 2011-12-14 Almirall, S.A. Topical pharmaceutical compositions comprising mometasone furoate
FR2969150B1 (fr) 2010-12-20 2013-07-26 Centre Nat Rech Scient Nouvelles molecules indoliques demontrant des activites antibacteriennes dans une variete de bacteries a gram-negatif et positif dont des bacteries multidrogues-resistantes
BR112015004666B1 (pt) 2012-09-07 2022-04-26 Novartis Ag Derivados de indol carboxamida, seu uso, e composição farmacêutica
CA2890748A1 (en) 2012-11-13 2014-05-22 Memorial Sloan-Kettering Cancer Center Indole compounds and their use as antimicrobials
US20170044100A1 (en) * 2014-04-22 2017-02-16 The Johns Hopkins University Inhibitors of drug-resistant mycobacterium tuberculosis
AU2015315174B2 (en) * 2014-09-10 2019-12-12 Epizyme, Inc. Smyd inhibitors
US9926261B2 (en) 2015-03-10 2018-03-27 Rutgers, The State University Of New Jersey Bacterial efflux pump inhibitors
US9950993B2 (en) 2015-03-13 2018-04-24 Rutgers, The State University Of New Jersey Bacterial efflux pump inhibitors
CN107709314A (zh) 2015-06-11 2018-02-16 巴斯利尔药物国际股份公司 外排泵抑制剂及其治疗性用途
EP3331530A4 (en) 2015-08-03 2018-12-19 Raze Therapeutics Inc. Mthfd2 inhibitors and uses thereof
US10836706B2 (en) 2016-02-24 2020-11-17 Rutgers, The State University Of New Jersey Bacterial efflux pump inhibitors
US10556854B2 (en) 2016-02-24 2020-02-11 Rutgers, The State University Of New Jersey Bacterial efflux pump inhibitors
EP4306166A3 (en) 2016-12-23 2024-06-26 Aquinnah Pharmaceuticals Inc. Compounds, compositions and methods of use
WO2018165612A1 (en) 2017-03-10 2018-09-13 Rutgers, The State University Of New Jersey Bacterial efflux pump inhibitors
EP3592736A1 (en) 2017-03-10 2020-01-15 Rutgers, the State University of New Jersey Indole derivatives as efflux pump inhibitors
WO2018165614A1 (en) 2017-03-10 2018-09-13 Rutgers, The State University Of New Jersey Bacterial efflux pump inhibitors
CN111163774A (zh) 2017-05-26 2020-05-15 罗格斯新泽西州立大学 细菌外排泵抑制剂
US11458121B2 (en) * 2017-06-26 2022-10-04 Rutgers, The State University Of New Jersey Therapeutic compounds and methods to treat infection
US20190031624A1 (en) 2017-07-28 2019-01-31 Rutgers, The State University Of New Jersey Therapeutic compounds and methods to treat infection
WO2019099402A1 (en) * 2017-11-14 2019-05-23 Rutgers, The State University Of New Jersey Therapeutic compounds and methods to treat infection

Similar Documents

Publication Publication Date Title
JP2020527597A5 (enExample)
CA2504448A1 (en) Transcription factor modulating compounds and methods of use thereof
JP7323179B2 (ja) 排出ポンプ阻害剤としてのインドール誘導体
FI3986419T3 (fi) Boorihappojohdannaisia ja niiden terapeuttisia käyttöjä
JP2017517567A5 (enExample)
RU2016107436A (ru) Линейные пептидные антибиотики
CN102762200B (zh) 作为抗微生物剂的增强剂的查尔酮
RU2018122505A (ru) Макроциклические антибиотики широкого спектра действия
JP2016528257A5 (enExample)
JP2021522167A5 (enExample)
SI2344129T1 (en) AEROSOL FLUOROKINOLONAL FORMULATIONS FOR IMPROVED PHARMACOKINETICS
JP2009541332A5 (enExample)
JP2016517851A5 (enExample)
FI4121058T3 (fi) Oksatsolidinoniyhdiste ja sen käyttö antibakteerisena aineena
JP2022505597A5 (enExample)
JP2001503411A (ja) 抗生物質耐性感染症の処置のための化合物、組成物および方法
US20190031624A1 (en) Therapeutic compounds and methods to treat infection
WO2004062674A2 (en) Substituted polyamines as inhibitors of bacterial efflux pumps
RU2018122498A (ru) Макроциклические антибиотики широкого спектра действия
JP2020507564A5 (enExample)
CA2768582A1 (en) Spectinamides as anti-tuberculosis agents
JP2022524151A5 (enExample)
Vaghela et al. Comparison of safety and analgesic efficacy of diclofenac sodium with etodolac after surgical extraction of third molars: a randomized, double-blind, double-dummy, parallel-group study
Iijima et al. Delayed healing of tooth extraction sockets with ramucirumab use
Morimoto et al. Haemostatic management for oral surgery in patients supported with left ventricular assist device–a preliminary retrospective study